Display Settings:

Format

Send to:

Choose Destination

    Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):8967-71.

    Expression cloning of a human corticotropin-releasing-factor receptor.

    Chen R, Lewis KA, Perrin MH, Vale WW.

    Clayton Foundation Laboratories for Peptide Biology, Salk Institute, La Jolla, CA 92037.

    Corticotropin-releasing factor (CRF) is the principal neuroregulator of the hypothalamic-pituitary-adrenocortical axis and plays an important role in coordinating the endocrine, autonomic, and behavioral responses to stress and immune challenge. We report here the cloning of a cDNA coding for a CRF receptor from a human corticotropic tumor library. The cloned cDNA encodes a 415-amino acid protein comprising seven putative membrane-spanning domains and is structurally related to the calcitonin/vasoactive intestinal peptide/growth hormone-releasing hormone subfamily of G protein-coupled receptors. The receptor expressed in COS cells binds rat/human CRF with high affinity (Kd = 3.3 +/- 0.45 nM) and specificity and is functionally coupled to adenylate cyclase. The CRF antagonist alpha-helCRF-(9-41) inhibits the CRF-stimulated increase in intracellular cAMP. Northern blot analysis reveals that the CRF receptor is expressed in the rat pituitary and brain as well as in the mouse AtT20 corticotropic cells. We also describe an alternatively spliced form of the receptor which includes an insert of 29 amino acids in the first intracellular loop.

    PMID: 7692441 [PubMed - indexed for MEDLINE]

    PMCID: 47482

    Supplemental Content

    Click here to read

    Patient drug information

    • Theophylline (Bronkodyl®, Elixophyllin®, Slo-bid®, ...)

      Theophylline is used to prevent and treat wheezing, shortness of breath, and difficulty breathing caused by asthma, chronic bronchitis, emphysema, and other lung diseases. It relaxes and opens air passages in the lungs, ...